Tetra Discovery Partners
9 clinical trials · Sponsor
◉ Watch Tetra Discovery Partners
| Record | Firm | Date |
|---|---|---|
| An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome (NCT05367960) | Tetra Discovery Partners | 2022-11-01 |
| A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome (NCT05358886) | Tetra Discovery Partners | 2022-11-01 |
| A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome (NCT05163808) | Tetra Discovery Partners | 2022-03-29 |
| A Phase 1, Open-Label, PET Study of T2310 & BPN14770 (NCT04044781) | Tetra Discovery Partners | 2020-01-10 |
| Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects (NCT03817684) | Tetra Discovery Partners | 2019-04-30 |
| A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome (NCT03569631) | Tetra Discovery Partners | 2018-07-09 |
Track Tetra Discovery Partners automatically
Every clearance here is in the API, with alerts when new ones post.